Model
Edge
Moonlake Immunotherapeutics
0001920553
Filing Type
4
Filing Date
10/2/2023
Updated
10/3/23, 1:27 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership